Principal Investigator
Marijo Bilusic
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231317
Clinical Trial Summary
DAREON-7: A Phase I, open-label, dose escalation and expansion trial to investigate safety and tolerability of BI 764532 intravenous infusions in combination with standard of care (platinum and etoposide) in first-line treatment of patients with neuroendocrine carcinomas (NEC)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
+1 (954) 8177628